Proglycem
- Product NDC
- 0575-6200
- 11-digit product format
- 005756200
- Labeler code
- 0575
- Product ID
- 0575-6200_451aa56d-e2e5-402f-843a-cddb5b3d37dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- diazoxide
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- NDA017453
- Marketing category
- NDA
- Marketing start
- 1990-09-30
- Substance
- DIAZOXIDE
- Active strength
- 50 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Proglycem
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DIAZOXIDE | 50 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O5CB12L4FN |
| Rxcui | 197593, 207634 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0575-6200-30 | Proglycem | 30 mL in 1 BOTTLE, DROPPER | SUSPENSION | 30 | | 15 |
| 0575-6200-30 | Proglycem | 1 in 1 BOX | SUSPENSION | 1 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DIAZOXIDE | ACTIVE INGREDIENT | O5CB12L4FN | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| DIAZOXIDE | ACTIVE MOIETY | O5CB12L4FN | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | INACTIVE INGREDIENT | K679OBS311 | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| MAGNESIUM ALUMINUM SILICATE | INACTIVE INGREDIENT | 6M3P64V0NC | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| POLOXAMER 188 | INACTIVE INGREDIENT | LQA7B6G8JG | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.] | 5 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0575-6200 | PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA PHARMACEUTICALS USA, INC.] | 15 | Current NDC, Legacy NDC, 2 package rows | 20240723_b16c7832-2fd9-49af-b923-1dc0d91fd6e2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0575-6200-30 | 00575620030 | 1 BOTTLE, DROPPER in 1 BOX (0575-6200-30) / 30 mL in 1 BOTTLE, DROPPER | 1990-09-30 | 0000-00-00 | No | No | Current |